about
Hypoxia-inducible factors as molecular targets for liver diseasesThe association between obstructive sleep apnea and metabolic syndrome: a systematic review and meta-analysisNonalcoholic fatty liver disease: Noninvasive methods of diagnosing hepatic steatosisIs Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?MyD88-dependent interplay between myeloid and endothelial cells in the initiation and progression of obesity-associated inflammatory diseases.Docosahexaenoic acid blocks progression of western diet-induced nonalcoholic steatohepatitis in obese Ldlr-/- mice.Nutrition and exercise in the management of liver cirrhosisAssociation between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects.Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo StudyDescription and prediction of the development of metabolic syndrome in Dongying City: a longitudinal analysis using the Markov model.Association between leukocyte and metabolic syndrome in urban Han Chinese: a longitudinal cohort study.Lipoprotein subclass metabolism in nonalcoholic steatohepatitis.IL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infectionCross-sectional and longitudinal evaluation of liver volume and total liver fat burden in adults with nonalcoholic steatohepatitisBranched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease.Increased susceptibility to methotrexate-induced toxicity in nonalcoholic steatohepatitis.Mechanistic basis of altered morphine disposition in nonalcoholic steatohepatitis.Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt.Defining the role of bariatric surgery in polycystic ovarian syndrome patients.Docosahexaenoic acid attenuates Western diet-induced hepatic fibrosis in Ldlr-/- mice by targeting the TGFβ-Smad3 pathway.Potential for dietary ω-3 fatty acids to prevent nonalcoholic fatty liver disease and reduce the risk of primary liver cancerRisk factors of non-communicable diseases and metabolic syndrome.Impact of dietary fat on the development of non-alcoholic fatty liver disease in Ldlr-/- mice.Bisphenol A sulfonation is impaired in metabolic and liver diseaseRisk factors for intrahepatic cholangiocarcinoma: association between metformin use and reduced cancer risk.The intraoperative glycemic response to intravenous insulin during noncardiac surgery: a subanalysis of the DeLiT randomized trial.Altered UDP-glucuronosyltransferase and sulfotransferase expression and function during progressive stages of human nonalcoholic fatty liver disease.DPP-4 Inhibitors as Therapeutic Modulators of Immune Cell Function and Associated Cardiovascular and Renal Insulin Resistance in Obesity and Diabetes.Non alcoholic fatty liver disease in a Nigerian population with type II diabetes mellitusPrimary hepatocellular carcinoma and metabolic syndrome: An update.Plasma lipidomic profile signature of hypertension in Mexican American families: specific role of diacylglycerolsAutophagy in Myf5+ progenitors regulates energy and glucose homeostasis through control of brown fat and skeletal muscle development.Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.Clustering and combining pattern of metabolic syndrome components among Iranian population with latent class analysis.Transcriptional regulation of PNPLA3 and its impact on susceptibility to nonalcoholic fatty liver Disease (NAFLD) in humans.The Metabolic Syndrome, Inflammation, and Colorectal Cancer Risk: An Evaluation of Large Panels of Plasma Protein Markers Using Repeated, Prediagnostic Samples.Review article: fructose in non-alcoholic fatty liver disease.Ginseng and diabetes: the evidences from in vitro, animal and human studies.Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: Where are we?Omega-3 polyunsaturated fatty acids as a treatment strategy for nonalcoholic fatty liver disease.
P2860
Q26752304-C475DBC8-DA06-486E-AA54-C549CC708EFCQ26782667-EFE78E4E-5AD3-4CD0-B1A4-365E221B7C02Q26858875-F713B307-56FA-43ED-B737-5FBA18FF01A8Q27330629-4AF9D00B-4071-48D6-93D8-712153EB7ECCQ33569870-88792970-26E1-4F1A-B43F-DA11F46A184DQ33579420-3737BF5E-F383-4A16-AAEA-6B6B87860627Q33780141-D5BA5059-2645-4556-93A9-5352CEA2FE4AQ33803656-CF66036F-0720-4B90-88F6-70F07D691382Q33851976-96A38708-4D62-4BB6-8886-EC99EF20AD5BQ34401940-25BD3C86-C4BF-4605-85B8-2E4C9B876C2CQ34499775-8CAA187C-9B00-47AF-8745-BFDB2EDA5B36Q34565315-3C279357-2997-4A7F-9ED7-5CD857A4873AQ34923937-AC72CFA6-DBB1-4832-B1D9-93C9290EE429Q34945781-A3786036-3150-4878-B91E-064F785EB605Q35085125-1957300A-A4F4-463B-8E0B-5A03D4B0060AQ35102604-44D61053-9F63-4BE5-9F8C-B26FE00DE48DQ35156418-263D9010-BB4E-4FE7-B2C3-434DFD88AA19Q35554147-7DDD898D-16BA-4C9B-B4C2-E9201138D2A6Q35906974-EDCAF676-868F-4727-AA17-A8193817FBA9Q36093199-E94DB65D-C35B-4451-A247-EC73EBEC495CQ36273224-512EFE8E-FFB0-436A-A803-2BEFC46E04C9Q36310986-4A2DACE6-6B9B-415C-AE20-1D793D304873Q36483906-10D08011-C1E4-42B5-B0F3-3AC642D1EA5FQ36495243-08275DCE-C7BC-40FE-8D2A-F435B904AE80Q36589096-64550D2B-55EB-44BB-B778-D99D600630AFQ36603188-399193C6-78B0-429F-B05A-73358596A610Q36642354-A36E8813-B335-44FA-A559-B56FA4D456FCQ37095161-0C2A7D65-6FAF-4483-85F9-105336A1F913Q37192372-A7D8BF5E-AB72-4BF8-9C67-3502EDFE37A0Q37196508-BFC58D81-4CDD-41AE-875E-7327D06A1B6FQ37211869-A688D253-40E1-476F-81A7-A52DF40C38D7Q37214016-2D170B55-CC42-4F33-B033-CED54BE225A3Q37258157-D5149041-25B4-48BC-8AE4-47B88302FCAAQ37640527-111237C2-D6E3-4912-8CAE-4188B334488FQ37643487-25E53A21-FBDC-4023-9861-80162AB17324Q37738141-70187D44-CD57-4247-8AF0-5D5C7B75580DQ37999116-1B0CA339-5818-4B01-AE2F-01718827D4AEQ38110276-818C1A8F-6001-4059-AF48-8AC3F3E04C91Q39013059-ECCA090B-AE2F-4267-8B28-77C50F7BA506Q39445103-8A2CF878-9CF4-43F9-9838-EE556AFD21DD
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Epidemiology of the metabolic syndrome in the USA
@ast
Epidemiology of the metabolic syndrome in the USA
@en
Epidemiology of the metabolic syndrome in the USA
@nl
type
label
Epidemiology of the metabolic syndrome in the USA
@ast
Epidemiology of the metabolic syndrome in the USA
@en
Epidemiology of the metabolic syndrome in the USA
@nl
prefLabel
Epidemiology of the metabolic syndrome in the USA
@ast
Epidemiology of the metabolic syndrome in the USA
@en
Epidemiology of the metabolic syndrome in the USA
@nl
P2860
P3181
P1476
Epidemiology of the metabolic syndrome in the USA
@en
P2093
Arthur J McCullough
P2860
P304
P3181
P356
10.1111/J.1751-2980.2010.00469.X
P407
P577
2011-10-01T00:00:00Z